Medical News

RSS

Labelling fails to address major knowledge gap on alcohol risks

The liquor industry’s decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.

12 Jul 2011

College drinkers with blackouts may face higher risk of alcohol-related injuries

"I don't remember how I got home from the party." This could be a text from last night to one hard-partying college student from another.

12 Jul 2011

Eating disorder behavior may directly affect brain function

Bulimia nervosa is a severe eating disorder associated with episodic binge eating followed by extreme behaviors to avoid weight gain such as self-induced vomiting, use of laxatives or excessive exercise.

12 Jul 2011

Gut hormone reduces willingness to pay for non-food items

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that ghrelin, a naturally occurring gut hormone, increases our willingness to pay for food, while simultaneously decreasing our willingness to pay for non-food items.

12 Jul 2011

Epidemiologic and physiologic research on sedentary behavior

Lack of physical exercise is often implicated in many disease processes. However, sedentary behavior, or too much sitting, as distinct from too little exercise, potentially could be a new risk factor for disease.

12 Jul 2011

College athletes smoke marijuana for different reasons

College athletes tend to be less likely than their non-athlete peers to smoke marijuana. But when they do, they may have some different reasons for it, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs.

12 Jul 2011

Biomet net sales increase 1% to $2.732 billion for fiscal year 2011

Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2011.

12 Jul 2011

Sunshine completes Adva-27a study in Multidrug Resistant Breast Cancer cell line

Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.

12 Jul 2011

American Red Cross issues appeal for donors to address critical blood shortage

The American Red Cross today issued an appeal for blood donors to roll up a sleeve and address a critical shortage across the nation.

12 Jul 2011

NY Times: Medical schools are adjusting their interest in 'people skills'

Doctors save lives, but they can sometimes be insufferable know-it-alls who bully nurses and do not listen to patients. Medical schools have traditionally done little to screen out such flawed applicants or to train them to behave better, but that is changing.

12 Jul 2011

Specific miRNAs play a key role in melanoma metastasis

Researchers at the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, identified for the first time the key role specific microRNAs play in melanoma metastasis to simultaneously cause cancer cells to invade and immunosuppress the human body's ability to fight abnormal cells.

12 Jul 2011

Study confirms link between phthalates and thyroid hormone levels in humans

A link between chemicals called phthalates and thyroid hormone levels was confirmed by the University of Michigan in the first large-scale and nationally representative study of phthalates and BPA in relation to thyroid function in humans.

12 Jul 2011

Study: 82% of Georgia hospitals do not offer palliative care services

Hospitals across the nation are increasingly implementing palliative care programs to help patients manage the physical and emotional burdens of serious illnesses, but a new University of Georgia study finds that 82 percent of the state's hospitals do not offer palliative care services.

12 Jul 2011

Federal funds may help Gladstone to solve problem of HIV latency

The Gladstone Institutes will receive funds totaling $5.6 million over five years as part of the first-ever major funding initiative focusing on HIV eradication.

12 Jul 2011

BioAlliance receives European patent for Livatag to treat primary liver cancer

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces the grant of a European patent protecting its Transdrug nanotechnology.

12 Jul 2011

Researchers identify obesity-related paradoxes among Chinese youth

Teenaged boys from well-off Chinese families who say they are physically active and eat plenty of vegetables but few sweets are more likely to be overweight, according to a study led by researchers at the Keck School of Medicine of the University of Southern California.

12 Jul 2011

Big news for ankylosing spondylitis sufferers

In a medical breakthrough, researchers from the University of Queensland have found that there is a possible genetic link in a specific painful form of arthritis, which fuses bones in the spine and pelvis.

12 Jul 2011

World's first double-leg transplant

Spanish surgeons, this Monday, performed the world's first double-leg transplant, giving an accident victim two new legs. Experts said it will be a month at least before the team will know if the procedure was a success. However if the legs are rejected that could happen immediately.

12 Jul 2011

American Tinnitus Association awards $10,000 to Wayne State University student

Na Zhu, a Wayne State University College of Engineering student, has received the 2011 American Tinnitus Association Student Research Grant Program award. The program financially supports scientific studies that investigate and aim to find a cure for tinnitus.

12 Jul 2011

Enrollment complete in Advaxis ADXS-HPV Phase II CIN study

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed enrollment of the first 40 subject cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.

12 Jul 2011